Search research articles
Contact Us
Filters
Showing results (301-310 of 351) with videos related to
Page
of 36
Sort By:
Plos One
|
December 30, 2020
IP-10 and CXCR3 signaling inhibit Zika virus replication in human prostate cells
Jennifer L Spencer Clinton, Linda L Tran, Megan B Vogt, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
June 1, 1997
[Volume and spatial representation of tumors in the core of the prostate gland]
L Salomon, M Colombel, J J Patard, et al.
Nature Immunology
|
August 24, 2004
Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type 1 polarization
Till A Röhn, Marianne Boes, Dirk Wolters, et al.
Plos Neglected Tropical Diseases
|
May 18, 2018
Mosquito saliva alone has profound effects on the human immune system
Megan B Vogt, Anismrita Lahon, Ravi P Arya, et al.
The EMBO Journal
|
June 26, 1998
A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules
H Kropshofer, A B Vogt, C Thery, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 1997
Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells
M Vergelli, B Hemmer, M Kalbus, et al.
European Journal of Immunology
|
March 4, 1999
Identification of destabilizing residues in HLA class II-selected bacteriophage display libraries edited by HLA-DM
L Raddrizzani, E Bono, A B Vogt, et al.
The American Journal of Managed Care
|
September 24, 2016
Geographic variation in surgical outcomes and cost between the United States and Japan
Michael P Hurley, Lena Schoemaker, John M Morton, et al.
The Journal of Cell Biology
|
June 12, 1998
Deficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: the Chediak-Higashi syndrome
W Faigle, G Raposo, D Tenza, et al.
Clinical Pharmacology and Therapeutics
|
November 7, 2008
Vascular effects of RWJ-676070, a selective combined V1a/V2 vasopressin receptor antagonist
L Coltamai, M Bucher, M P Maillard, et al.
Page
of 36
Search research articles
Search
Showing results (301-310 of 351) with videos related to
Sort By:
Page
of 36
Plos One
|
December 30, 2020
IP-10 and CXCR3 signaling inhibit Zika virus replication in human prostate cells
Jennifer L Spencer Clinton, Linda L Tran, Megan B Vogt, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
June 1, 1997
[Volume and spatial representation of tumors in the core of the prostate gland]
L Salomon, M Colombel, J J Patard, et al.
Nature Immunology
|
August 24, 2004
Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type 1 polarization
Till A Röhn, Marianne Boes, Dirk Wolters, et al.
Plos Neglected Tropical Diseases
|
May 18, 2018
Mosquito saliva alone has profound effects on the human immune system
Megan B Vogt, Anismrita Lahon, Ravi P Arya, et al.
The EMBO Journal
|
June 26, 1998
A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules
H Kropshofer, A B Vogt, C Thery, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 1997
Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells
M Vergelli, B Hemmer, M Kalbus, et al.
European Journal of Immunology
|
March 4, 1999
Identification of destabilizing residues in HLA class II-selected bacteriophage display libraries edited by HLA-DM
L Raddrizzani, E Bono, A B Vogt, et al.
The American Journal of Managed Care
|
September 24, 2016
Geographic variation in surgical outcomes and cost between the United States and Japan
Michael P Hurley, Lena Schoemaker, John M Morton, et al.
The Journal of Cell Biology
|
June 12, 1998
Deficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: the Chediak-Higashi syndrome
W Faigle, G Raposo, D Tenza, et al.
Clinical Pharmacology and Therapeutics
|
November 7, 2008
Vascular effects of RWJ-676070, a selective combined V1a/V2 vasopressin receptor antagonist
L Coltamai, M Bucher, M P Maillard, et al.
Page
of 36